Literature DB >> 16487640

Building effective public-private partnerships: experiences and lessons from the African Comprehensive HIV/AIDS Partnerships (ACHAP).

Ilavenil Ramiah1, Michael R Reich.   

Abstract

This paper examines the processes for building highly collaborative public-private partnerships for public health, with a focus on the efforts to manage the complex relationships that underlie these partnerships. These processes are analyzed for the African Comprehensive HIV/AIDS Partnerships (ACHAP), a 5-year partnership (2001-2005) between the government of Botswana, Merck & Co., Inc. (and its company foundation), and the Bill & Melinda Gates Foundation. ACHAP is a highly collaborative initiative. The ACHAP office in Botswana engages intensively (on a daily basis) with the government of Botswana (an ACHAP partner and ACHAP's main grantee) to support HIV/AIDS control in that country, which had an adult prevalence of 38.5% HIV infection in 2000 when ACHAP was being established. The paper discusses the development of ACHAP in four stages: the creation of ACHAP, the first year, the second and third years, and the fourth year. Based on ACHAP's experiences over these four years, the paper identifies five lessons for managing relationships in highly collaborative public-private partnerships for public health.

Entities:  

Mesh:

Year:  2006        PMID: 16487640     DOI: 10.1016/j.socscimed.2006.01.007

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  9 in total

1.  Addressing the implementation gap in global road safety: exploring features of an effective response and introducing a 10-country program.

Authors:  Adnan A Hyder; Katharine A Allen; Gayle Di Pietro; Claudia A Adriazola; Rochelle Sobel; Kelly Larson; Margie Peden
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  Global public-private health partnerships: lessons learned from ten years of experience and evaluation.

Authors:  Kent Buse; Sonja Tanaka
Journal:  Int Dent J       Date:  2011-08       Impact factor: 2.607

Review 3.  Pharmaceutical industry, non-communicable diseases and partnerships: More questions than answers.

Authors:  David Beran; Margaret Ewen; François Chappuis; Tim Reed; Hans Hogerzeil
Journal:  J Glob Health       Date:  2017-12       Impact factor: 4.413

4.  Exploring shared risks through public-private partnerships in public health programs: a mixed method.

Authors:  Wadi B Alonazi
Journal:  BMC Public Health       Date:  2017-06-12       Impact factor: 3.295

5.  Assessing the Impact of Airborne Outreach to Build Clinical Capacity in Rural Botswana.

Authors:  Michael J A Reid; Brianna L Kirk
Journal:  J Public Health Afr       Date:  2013-10-15

6.  Understanding the complex relationships among actors involved in the implementation of public-private mix (PPM) for TB control in India, using social theory.

Authors:  Solomon Salve; Kristine Harris; Kabir Sheikh; John D H Porter
Journal:  Int J Equity Health       Date:  2018-06-07

7.  Public-private partnerships in primary health care: a scoping review.

Authors:  Nasrin Joudyian; Leila Doshmangir; Mahdi Mahdavi; Jafar Sadegh Tabrizi; Vladimir Sergeevich Gordeev
Journal:  BMC Health Serv Res       Date:  2021-01-04       Impact factor: 2.655

Review 8.  'Public enemy no. 1': Tobacco industry funding for the AIDS response.

Authors:  Julia Smith; Sheryl Thompson; Kelley Lee
Journal:  SAHARA J       Date:  2016

9.  Is universal access to antiretroviral drugs an emerging international norm?

Authors:  Jeremy Youde
Journal:  J Int Relat Dev (Ljubl)       Date:  2008-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.